In a paper in this months PLoS Medicine, researchers from the Genome Institute of Singapore describe the identification of a human cellular protein that has a significant effect on the replication efficiency of Hepatitis B virus. Lisa F. P. Ng and colleagues found the protein--hnRNPK--when they noted an association between one particular sequence in the Hepatitis B virus and high levels of the virus in some infected patients. They discovered that how well the virus replicated is determined by a combination of sequence differences of the virus and how well hnRNPK binds to the viral DNA.
Hepatitis B is a serious global public health problem; more than 350 million people have lifelong infections. Chronically infected people are at high risk of death from cirrhosis of the liver and liver cancer, which both kill about 1 million people each year. Current antiviral therapies include lamivudine and alpha-interferon which also suppress viral replication by attacking the virus itself, but the identification of the action of this protein offers new therapeutic opportunities by targeting the human proteins that help the virus to replicate.
Paul Ocampo | Source: EurekAlert!
Further information: www.plosmedicine.org
www.plos.org
More articles from
Life Sciences:
New beta-blocker to offer hope to heart and lung sufferers
29.08.2008 | University of Nottingham
Antidepressants Need New Nerve Cells to be Effective
29.08.2008 | UT Southwestern Medical Center
29.08.2008 | Information Technology
Why did the squirrel cross the road?
29.08.2008 | Studies and Analyses
Revealed: The secret of plasma heating
29.08.2008 | Physics and Astronomy